ALK and inflammatory breast carcinoma: A set of 25 randomly selected IBC patient tumors were analyzed using the FDA approved fluorescence in situ hybridization (FISH) detection method based on the Vysis ALK Break Apart Probe for detection of EML-4-ALK translocation and gene amplification (Shaw et al. 2011).